DK1073431T3 - Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom - Google Patents

Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom

Info

Publication number
DK1073431T3
DK1073431T3 DK99947024T DK99947024T DK1073431T3 DK 1073431 T3 DK1073431 T3 DK 1073431T3 DK 99947024 T DK99947024 T DK 99947024T DK 99947024 T DK99947024 T DK 99947024T DK 1073431 T3 DK1073431 T3 DK 1073431T3
Authority
DK
Denmark
Prior art keywords
bowel syndrome
irritable bowel
nmda antagonists
treat irritable
treat
Prior art date
Application number
DK99947024T
Other languages
English (en)
Inventor
Aziz Asghar
Anne King
Jose Luis Cabero
Andrew Dray
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9801494A external-priority patent/SE9801494D0/xx
Priority claimed from SE9803954A external-priority patent/SE9803954D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1073431T3 publication Critical patent/DK1073431T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK99947024T 1998-04-28 1999-04-28 Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom DK1073431T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801494A SE9801494D0 (sv) 1998-04-28 1998-04-28 Novel use
SE9803954A SE9803954D0 (sv) 1998-11-18 1998-11-18 Novel use

Publications (1)

Publication Number Publication Date
DK1073431T3 true DK1073431T3 (da) 2004-10-04

Family

ID=26663287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99947024T DK1073431T3 (da) 1998-04-28 1999-04-28 Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom

Country Status (21)

Country Link
EP (1) EP1073431B1 (da)
JP (1) JP2002512956A (da)
KR (1) KR100569777B1 (da)
CN (1) CN1200702C (da)
AR (1) AR016212A1 (da)
AT (1) ATE270545T1 (da)
AU (1) AU760783B2 (da)
BR (1) BR9909971A (da)
CA (1) CA2329328A1 (da)
DE (1) DE69918541T2 (da)
DK (1) DK1073431T3 (da)
ES (1) ES2221753T3 (da)
HK (1) HK1033876A1 (da)
IL (1) IL138919A0 (da)
MY (1) MY121063A (da)
NO (1) NO20005386L (da)
NZ (1) NZ507436A (da)
PT (1) PT1073431E (da)
SA (1) SA99200482B1 (da)
TW (1) TW570793B (da)
WO (1) WO1999055323A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60107393T2 (de) * 2000-03-01 2005-12-01 Euro-Celtique S.A. Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten
TW593223B (en) * 2000-06-20 2004-06-21 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
JP2003081872A (ja) * 2001-09-13 2003-03-19 Nippon Oruganon Kk 掻痒治療薬
DE602004009414T2 (de) * 2003-03-14 2008-07-24 Agi Therapeutics Research Ltd. Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo-[2.2.1]heptan-2-amin
WO2004084889A1 (en) * 2003-03-28 2004-10-07 Pfizer Inc. Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
FR2865133B1 (fr) * 2004-01-19 2008-01-18 Rytek Compositions pour le traitement de pathologies digestives
EP3817746A4 (en) * 2018-07-06 2022-04-06 Algernon Pharmaceuticals Inc. COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES AND METHODS THEREOF
KR102211282B1 (ko) 2019-11-20 2021-02-03 (주)파이브텍 데이터 라우팅 방법 및 이를 지원하는 스위치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84305A (en) * 1987-02-06 1992-01-15 Fisons Corp 2-aminoacetamide derivatives
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition

Also Published As

Publication number Publication date
KR20010043077A (ko) 2001-05-25
EP1073431A1 (en) 2001-02-07
SA99200482B1 (ar) 2006-06-27
JP2002512956A (ja) 2002-05-08
DE69918541D1 (de) 2004-08-12
TW570793B (en) 2004-01-11
AR016212A1 (es) 2001-06-20
DE69918541T2 (de) 2005-08-18
AU4302499A (en) 1999-11-16
AU760783B2 (en) 2003-05-22
NZ507436A (en) 2003-09-26
IL138919A0 (en) 2001-11-25
KR100569777B1 (ko) 2006-04-11
WO1999055323A1 (en) 1999-11-04
BR9909971A (pt) 2000-12-26
CN1307471A (zh) 2001-08-08
MY121063A (en) 2005-12-30
CN1200702C (zh) 2005-05-11
ATE270545T1 (de) 2004-07-15
PT1073431E (pt) 2004-10-29
HK1033876A1 (en) 2001-09-28
NO20005386D0 (no) 2000-10-26
EP1073431B1 (en) 2004-07-07
NO20005386L (no) 2000-10-26
CA2329328A1 (en) 1999-11-04
ES2221753T3 (es) 2005-01-01

Similar Documents

Publication Publication Date Title
DK1126826T3 (da) Multipartikel-modificeret-frigivelsessammensætning af methylphenidat
PT945132E (pt) Composicao de ibuprofeno
DK1161232T3 (da) Hydroxydiphenylureasulfonamider som IL-8-receptorantagonister
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
PT1049695E (pt) Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
DE60026734D1 (de) Brücke zur can-tcp/ip-verbindung
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
PT1250321E (pt) Composicao de gliburida
DK0831721T3 (da) Dej- og paneringsbelagte levnedsmiddelsammensætninger ved anvendelse af calciumpectiner
NO994626D0 (no) Substituerte benzamider
DE69930547D1 (de) Reinigungszusammensetzung
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
DK1073431T3 (da) Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
PT1022396E (pt) Combinacao de duche
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
DE69707098D1 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DK0947492T3 (da) Fremgangsmåde til fremstilling af citral
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
DE69929223D1 (de) Reinigungsmittelzusammensetzungen
DK1250148T3 (da) Anvendelse af FSH til behandling af infertilitet
PT1175417E (pt) Compostos substituidos de benzolactamas
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
ID30381A (id) Penggunaan arilalkanoilpiridazina